EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study

Mmadili N Ilozumba, Tengda Lin, Sheetal Hardikar iD, Doratha A Byrd, June L Round, W Zac Stephens, Andreana N Holowatyj, Christy A Warby, Victoria Damerell, Christopher I Li iD, Jane C Figueiredo, Adetunji T Toriola iD und 9 weitere

Cancer Medicine · 2024

DOI: 10.1002/cam4.70431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Mmadili N Ilozumba und 20 weiteren Autor:innen. Beteiligte Einrichtung: Huntsman Cancer Institute, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cachexia, Fusobacterium nucleatum, Feces. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, German Cancer Research Center, the Rahel-Goitein-Straus-Program, Medical Faculty Heidelberg University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cachexia accounts for about 20% of all cancer‐related deaths and indicates poor prognosis. The impact of Fusobacterium nucleatum (Fn ), a microbial risk factor for colorectal cancer (CRC), on the development of cachexia in CRC has not been established.

Methods

We evaluated the association between Fn abundance in pre‐surgical stool samples and onset of cachexia at 6 months post‐surgery in n = 87 patients with stages I–III CRC in the ColoCare Study.

Results

High fecal Fn abundance compared to negative/low fecal Fn abundance was associated with 4‐fold increased risk of cachexia onset at 6 months post‐surgery (OR = 4.82, 95% CI = 1.15, 20.10, p = 0.03).

Conclusion

Our findings suggest that high fecal Fn abundance was associated with an increased risk of cachexia at 6 months post‐surgery in CRC patients. This is the first study to link Fn abundance with cachexia in CRC patients, offering novel insights into biological mechanisms and potential management of cancer cachexia. Due to the small sample size, our results should be interpreted with caution. Future studies with larger sample sizes are needed to validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCachexiaFusobacterium nucleatumFecesHumansMaleFemaleAgedMiddle AgedFusobacterium InfectionsNeoplasm StagingRisk Factors

Stichwörter der Autor:innen

Fusobacterium nucleatumcachexiacolorectal cancer

Autor:innen und Institutionen

  • Huntsman Cancer Institute, Salt Lake City, Utah, USA.
  • Department of Population Sciences, University of Utah, USA.
  • H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of General, Visceral, and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.

ORCID-Profile: Sheetal Hardikar, Christopher I Li, Adetunji T Toriola, Cornelia M Ulrich

Förderung

  • NCI NIH HHS
  • German Cancer Research Center
  • the Rahel-Goitein-Straus-Program, Medical Faculty Heidelberg University
  • the German Consortium of Translational Cancer Research, (DKTK)
  • Huntsman Cancer Foundation
  • NIA NIH HHS
  • ERA-NET (European Research Area Network) on Translational Cancer Research (TRANSCAN) project
  • the German Ministry of Education and Research project PerMiCCion (01KD2101D)

Zitieren

APA

Ilozumba, M. N., Lin, T., Hardikar, S., Byrd, D. A., Round, J. L., Stephens, W. Z., Holowatyj, A. N., Warby, C. A., Damerell, V., Li, C. I., Figueiredo, J. C., Toriola, A. T., Shibata, D., Fillmore, G. C., Pickron, B., Siegel, E. M., Kahlert, C., Florou, V., Gigic, B., …, & Ulrich, C. M. (2024). Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study. Cancer Medicine. https://doi.org/10.1002/cam4.70431

Vancouver

Ilozumba MN, Lin T, Hardikar S, Byrd DA, Round JL, Stephens WZ, et al. Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study. Cancer Medicine. 2024. doi:10.1002/cam4.70431

BibTeX
@article{Ilozumba2024,
  author = {Ilozumba, Mmadili N and Lin, Tengda and Hardikar, Sheetal and Byrd, Doratha A and Round, June L and Stephens, W Zac and Holowatyj, Andreana N and Warby, Christy A and Damerell, Victoria and Li, Christopher I and Figueiredo, Jane C and Toriola, Adetunji T and Shibata, David and Fillmore, Gary C and Pickron, Bartley and Siegel, Erin M and Kahlert, Christoph and Florou, Vaia and Gigic, Biljana and Ose, Jennifer and Ulrich, Cornelia M},
  title = {Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70431}
}
Kostenlos starten →